Barinthus Biotherapeutics plc (BRNS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.37M | -4.2M | -10.73M | -18.11M | -14.9M | 13.09M | -18.2M | -12.01M | -11.82M | -19.6M | -11.19M | -16.96M | -3.17M | -11.34M | 11.88M | -8.39M | -6.58M | -7.97M | -2.02M | -14.62M |
| Operating CF Margin % | - | - | - | - | - | - | -121.57% | - | - | - | - | -5076.95% | -678.21% | -175.67% | 192.77% | -49.19% | -43.81% | 797200% | -10621.05% | -41782.86% |
| Operating CF Growth % | 77.41% | -132.07% | 41.06% | -50.83% | -26.05% | 166.76% | -62.61% | 29.2% | -272.46% | -72.82% | -194.17% | -102.04% | 51.76% | -42.29% | 688.9% | 42.61% | 17.44% | -62.83% | - | - |
| Net Income | -5.53M | -11.07M | -14.57M | -21.13M | -19.66M | -20.59M | -8.13M | -16.94M | -15.52M | -17.29M | -14.11M | -23.82M | -18.22M | -21.16M | 8.22M | 15.69M | 2.57M | -15.17M | -4.57M | -15.98M |
| Depreciation & Amortization | 856K | 907.69K | 901K | 2M | 2.03M | 1.43M | 1.48M | 1.47M | 1.43M | 1.44M | 1.47M | 1.3M | 1.22M | 1.18M | 1.19M | 992K | 966K | 321K | 85K | 104K |
| Stock-Based Compensation | 556K | 0 | -415K | -281K | 468K | 755K | 1.14M | 1.2M | 1.61M | 786K | 57K | 1.99M | 2.22M | 2.04M | 1.1M | 2.75M | 3.98M | 3.58M | 3.37M | 8.74M |
| Deferred Taxes | -16K | -56.98K | -71K | -25K | -22K | 3K | -3K | -7K | -37K | 0 | -602K | -1.14M | -516K | -1.93M | -625K | -915K | -863K | -57K | -30K | -7K |
| Other Non-Cash Items | 772K | 2.58M | 4.89M | 3.52M | 2.41M | 16.34M | 2.61M | 826K | -595K | 2.56M | -6.27M | 4.17M | 3.87M | 11.11M | -17.62M | -17.96M | 383K | 348K | -32K | 11K |
| Working Capital Changes | 0 | 3.45M | -1.46M | -2.2M | -137K | 15.15M | -15.29M | 1.46M | 1.28M | -7.09M | 8.26M | 542K | 8.25M | -2.57M | 19.62M | -8.95M | -13.62M | 3.01M | -845K | -7.48M |
| Change in Receivables | 0 | 3.47M | -145K | -1.16M | 4.25M | 12.86M | -15.55M | 683K | -331K | 0 | -966K | 129K | 7.06M | 324K | 11.64M | 412K | -17.05M | -719K | -978K | -604K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 644K | -346.47K | -1.04M | 342K | -1.16M | -460K | 391K | 1.49M | -524K | 0 | 2.33M | -209K | -1.71M | 998K | -634K | -963K | 1.74M | -114K | -1.87M | -840K |
| Cash from Investing | 55K | 1.48K | 451K | -32K | -5K | -278K | -114K | -192K | -308K | 153K | -36K | -3.02M | -2.51M | -586K | -2.02M | -2.05M | -1.09M | -12.19M | -128K | -202K |
| Capital Expenditures | 0 | 47 | 451K | -32K | -5K | -278K | -114K | -192K | -308K | 153K | -36K | -3.02M | -2.51M | -586K | -2.41M | -2.05M | -1.09M | -424K | -128K | -202K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.76% | - | - | - | - | 905.09% | 535.68% | 9.08% | 39.03% | 12.04% | 7.27% | -42400% | 673.68% | 577.14% |
| Acquisitions | 0 | 1.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 388K | 0 | 0 | -11.77M | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 0 | 2K | 837K | 465K | 358K | 503K | 109K | 46K | 28K | 1.69M | 484K | 0 | 0 | -159K | 9K | -1.39M | 102.31M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -159K | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 837K | 465K | 358K | 503K | 0 | 46K | 91K | 1.79M | 484K | 0 | 0 | 0 | -287K | 0 | 103.06M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 109K | 0 | -63K | -100K | 0 | 0 | 0 | 0 | 296K | -1.39M | -756K |
| Net Change in Cash | -4.66M | -3.82M | -12.11M | -12.79M | -11.82M | 6.3M | -11.67M | -12.2M | -12.12M | -18.22M | -12.72M | -18.3M | -3.06M | -5.72M | 7.78M | -8.27M | -13.46M | -19.82M | -9.75M | 87.68M |
| Free Cash Flow | -3.37M | -4.2M | -10.73M | -18.14M | -14.91M | 12.81M | -18.31M | -12.2M | -12.13M | -19.45M | -11.23M | -19.98M | -5.68M | -11.93M | 9.48M | -10.45M | -7.67M | -8.4M | -2.15M | -14.83M |
| FCF Margin % | - | - | - | - | - | - | -122.33% | - | - | - | - | -5982.04% | -1213.89% | -184.75% | 153.74% | -61.23% | -51.08% | 839600% | -11294.74% | -42360% |
| FCF Growth % | 77.42% | -132.76% | 41.43% | -48.72% | -22.89% | 165.85% | -63.11% | 38.95% | -113.52% | -63.05% | -218.45% | -91.25% | 25.94% | -42.08% | 541.66% | 29.54% | 8.25% | -64.92% | - | - |
| FCF per Share | -0.08 | -0.10 | -0.26 | -0.45 | -0.37 | 0.33 | -0.46 | -0.31 | -0.31 | -0.50 | -0.29 | -0.52 | -0.15 | -0.32 | 0.25 | -0.27 | -0.20 | -0.23 | -0.06 | -0.60 |
| FCF Conversion (FCF/Net Income) | 0.61x | 0.38x | 0.74x | 0.86x | 0.76x | -0.64x | 2.24x | 0.71x | 0.76x | 1.13x | 0.80x | 0.71x | 0.17x | 0.54x | 1.44x | -0.53x | -2.53x | 0.53x | 0.44x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 150K |